MedTrace Logo

Cognitive Remediation Therapy and Schizophrenia

NCT01078129 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 77

Last updated 2014-02-25

No results posted yet for this study

Summary

Objectives:

The purpose of this study is to determine the impact of a new Cognitive Remediation Therapy (CRT) on cognition, social autonomy, symptoms and brain functioning in patients with schizophrenia.

Conditions

Interventions

BEHAVIORAL

cognitive remediation therapy

program consisting of 14 training sessions of 4 cognitive functions (attention/concentration, topological memory, logical reasoning, executive functions)by means REHACOM® software

BEHAVIORAL

non-CRT

waiting list

Sponsors & Collaborators

  • University Hospital, Grenoble

    collaborator OTHER

  • University Hospital, Clermont-Ferrand

    collaborator OTHER

  • Hôpital le Vinatier

    lead OTHER

Principal Investigators

  • Thierry d'amato, MD, PhD · Hopital le Vinatier

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2006-01-31
Primary Completion
2008-03-31
Completion
2010-12-31

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01078129 on ClinicalTrials.gov